Home > Insider Trading > Filing (0000850261-18-000009)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850261	Sorrento Therapeutics Inc.	SRNE	Services-Commercial Physical & Biological Research (8731)	330344842

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470981	Henry Ji	C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-28	124,298	$0.00	260,161	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2018-02-28	64,600	$9.95	1,906,177	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	See Footnote
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,153,162	Indirect	See Footnote
Common Stock	29,001	Indirect	By spouse

Footnotes

Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. ("Scilex"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the "Stock Purchase Agreement"), an entity of which the Reporting Person and his spouse are the sole members and managing directors sold 1,368,681 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on February 28, 2018, the Issuer issued such entity 124,298 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $9.95 per share. Contingent upon the achievement of such milestone, such entity's right to receive such shares became fixed and irrevocable on November 8, 2016.
Shares are held by an entity of which the Reporting Person and his spouse are the sole members and managing directors.
Shares are held in a family trust of which the Reporting Person is a co-trustee with his wife.